TrumpCare’s Tax Gift to Pharma Raises Premiums By Billions in Medicare Part B

New Data from CMS Actuary Shows $8.7 Billion in Higher Medicare Premiums for Seniors, Individuals with Disabilities Due to Tax Break for Pharmaceutical Drug Companies Revelation of Higher Premiums Comes After News That Payroll Tax Cut for Wealthy Would Force Medicare Part A Trust Fund Into Crisis Three Years Earlier than Expected WASHINGTON – Senate […]

Wyden Asks HHS to Ensure Verma Complies with Ethics Agreement

WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today sent a letter to Department of Health and Human Services (HHS) Acting General Counsel Jeffrey Davis requesting information about how the agency will ensure CMS Administrator Seema Verma is in compliance with her ethics agreements not to directly work on matters relating to seven […]

Wyden and Pallone to Price: No Authority to Approve Harmful Medicaid Waivers

WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and House Energy and Commerce Committee Ranking Member Frank Pallone Jr., D-N.J., today sent a letter to Health and Human Services (HHS) Secretary Tom Price reminding him that Medicaid waivers cannot be approved by the agency if they are not in line with the objectives […]

Wyden Slams Republican Vote to Create “Bedlam” for Drug Testing of Unemployed Americans

Washington, D.C. – U.S. Sen. Ron Wyden, D-Ore., today slammed a Republican vote to overturn a U.S. Department of Labor rule that clarified drug testing practices for state unemployment insurance programs. In a speech on the Senate floor today, Wyden called drug testing for unemployment insurance recipients in the middle of an opioid epidemic “ineffective […]

Wyden Calls for Increased Drug Pricing Transparency to Lower Costs

Ranking Finance Democrat Introduces Bill to Shine a Light on PBM Rebates in Medicare C-THRU Act Would Also Ensure Savings are Passed Along to Seniors WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today introduced legislation that would, for the first time, require Pharmacy Benefit Managers (PBMs) in Medicare to disclose their aggregate […]

Wyden Statement at Finance Committee Hearing on Lighthizer Nomination for USTR

After several weeks during which the only insight the public has gotten into this administration’s trade policy has come in head-scratching 140-character bursts, today’s hearing may finally provide some real specifics. I want to thank Mr. Lighthizer for being here today as the committee considers his nomination to be the U.S. Trade Representative. And I […]

Wyden Statement on CBO Score of Trumpcare

Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement: “The CBO score confirms what many feared: Trumpcare is an awful deal for the American people. It will leave 24 million Americans in the cold with no health insurance, despite promises that everybody would be covered. It would raise out-of-pocket costs by thousands […]

Wyden Statement on Senate Floor on Seema Verma Nomination and Trumpcare

Today the Senate turns to consider the nomination of Seema Verma to be the administrator of the Centers of Medicare and Medicaid Services. Now I’ll admit, people in coffee shops across America probably aren’t atwitter with the latest buzz out of CMS. But the fact is, this is an agency that controls more than a […]